Insulet | PODD - Lucro Operacional





Lucro Operacional Alterar Data
Abbott USD 2.13B 281M 2026-06
Align Technology USD 191.32M 13.27M 2026-06
AtriCure USD 9.66M 9.14M 2026-06
Baxter International USD 276M 210M 2026-06
Becton, Dickinson and Co. USD 627M 36M 2026-03
Boston Scientific USD 1.24B 190M 2026-06
Cardinal Health USD 861M 98M 2026-03
Cooper Companies USD -31M 243.8M 2026-03
Dexcom USD 318.3M 63M 2026-06
Edwards Lifesciences USD 519.5M 4.8M 2026-06
Eli Lilly USD 9.78B 792M 2026-03
Globus Medical USD 164M 17.31M 2026-03
ICU Medical USD 26.09M 770K 2025-12
Inogen USD -7.79M 728K 2024-09
Insulet USD 122M 24.3M 2026-03
Integra LifeSciences USD 41.29M 29.82M 2026-06
J&J USD 7.48B 860M 2026-06
Medtronic USD 2.09B 354M 2026-03
Merit Medical Systems USD 60.4M 16.25M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Solventum Corp USD 85M 20M 2026-03
Stryker USD 1.79B 687M 2026-06
Tandem Diabetes Care USD 8.29M 31.16M 2025-12
Teleflex USD 37.03M 686K 2026-03
West Pharmaceutical Services USD 179.1M 2M 2026-06
Zimmer Biomet Holdings USD 395.1M 92.2M 2026-03